http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#Head
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#assertion
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#provenance
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#pubInfo
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#assertion
http://purl.obolibrary.org/obo/MONDO_0001087
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/MONDO_0001087
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/DRUGBANK:DB01267
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#association
http://www.w3.org/2000/01/rdf-schema#label
Similarly, De Cos Milas et al. [6] described their clinical experience with paliperidone in adolescents. They presented 3 males and 2 females, age between 15 and 17 years. Diagnoses were autism, borderline personality disorder, schizotypal personality disorder, personality disorder not otherwise specified, and schizophrenia. Prescribed dose was 3–9 mg/day, and actual mean time of treatment duration is 5.8 months. In 4 cases, paliperidone was initiated as a change from other antipsychotic. There were no adverse effects that required discontinuation and in all cases symptoms improved.
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#association
https://w3id.org/biolink/vocab/has_population_context
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#context
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#association
https://w3id.org/biolink/vocab/publications
https://pubmed.ncbi.nlm.nih.gov/31096228
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#association
https://w3id.org/biolink/vocab/relation
https://w3id.org/um/neurodkg/OffLabelIndication
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#context
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
https://w3id.org/biolink/vocab/Cohort
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#context
http://www.w3.org/2000/01/rdf-schema#label
Adolescents (15-17)
https://identifiers.org/DRUGBANK:DB01267
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#provenance
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#assertion
http://www.w3.org/ns/prov#generatedAtTime
2021-08-24T16:13:47.586648
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#pubInfo
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#sig
http://purl.org/nanopub/x/hasSignature
GqT07hBN6al0Vf9zMLUZYNzBCP2WgoGtVEi1VIIjzx7DszQkCsPChUxAeFYXFkkJTi/Z/qgmVFi2SvV79CLKc13RJvQXvBfyFBBGGGCFmfnKTMBESghqW8/+WwQLkPz6tOUzfoJxKW5+LWXCcq5p2gN+XVWWYcOk9CFa/O50QMs=
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I
http://www.w3.org/ns/prov#generatedAtTime
2021-08-24T16:13:47.586648
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-7641-6446
http://purl.org/np/RAHodixunoqzaITalxgrphj3GSLFoaPG-vG82Yq7w5F6I
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY